Should women take creatine? Dietitians explain benefits, risks and what to know before trying it
Does creatine have benefits for women? A dietitian shares how it can help with muscle, reproductive and mental health and ...
GlobalData on MSN14h
WhiteSwell’s eLym System trial indicates positive outcomes for ADHF patients
The eLym System was deployed in all subjects, with each one experiencing weight loss and showing improvement in peripheral oedema and orthopnoea. Mean weight loss from baseline to ...
Incredible moment Beast Games contestant wins $10 million in dramatic Amazon show finale
The show began with 1,000 players competing in a series of tasks that challenged contestants to use their decision-making ...
I was on death's door and had a groundbreaking op. They said my new organ would last for a couple of years at best. But 50 years later, it's still going strong... thanks to ...
When Mike Shepherdson had a life-saving kidney transplant at the age of 13, the expectation was that, at best, it would work ...
Palatin Technologies, Inc. (AMEX:PTN) Q2 2025 Earnings Call Transcript
Palatin Technologies, Inc. (AMEX: PTN) Q2 2025 Earnings Call Transcript February 13, 2025 ...
The American Journal of Managed Care15h
5 Things That Impact Heart Health
To maintain a healthy heart, researchers say people should focus on diet and exercise, limit alcohol, manage stress, get ...
Health on MSN21h
Biohacking Explained: How It Works, Benefits, and Beginner Tips
Medically reviewed by Arno Kroner, DAOM Biohacking describes changes people make to their bodies to improve their physical or ...
unilad11h
Incredible moment contestant wins record-breaking $10,000,000 on MrBeast's BeastGames
Famous YouTuber, MrBeast - real name is Jimmy Donaldson - is renowned for giving out life-changing sums of money and ...
FiercePharma6h
FDA approves Ono's rare tumor drug from $2.4B Deciphera buyout
A new FDA approval stands to give Daiichi Sankyo’s Turalio some company in a rare tumor type. | The new FDA approval gives ...
Targeted Oncology7h
Vimseltinib Gains FDA Approval in Tenosynovial Giant Cell Tumor
Vimseltinib is now an FDA-approved treatment for patients with tenosynovial giant cell tumor, based on findings from the ...
AFP1h
U.S. FDA Grants Full Approval of Deciphera’s ROMVIMZA™ (vimseltinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumor (TGCT)
Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S. Food and Drug Administration (FDA) has approved ROMVIMZA™ (vimseltinib), a kinase ...